生物治疗方案在皮肤和全身巨细胞瘤的使用:一个范围审查
Journal of drugs in dermatology : JDD
|July 8, 2025
概括
新型生物疗法,包括氨酸激酶抑制剂 (TKI) 和单克隆抗体,在治疗诸如系统性乳腺细胞瘤 (SM) 等乳腺细胞瘤亚型方面表现出高效. 需要对JAK1/2抑制剂进行进一步的研究.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳腺细胞瘤包括系统性乳腺细胞瘤 (SM),皮肤性乳腺细胞瘤 (CM) 和乳腺细胞肉瘤 (MCS),预后不同.
- 生物和基因测试的进步为巨细胞瘤提供了新的治疗途径.
- 本综述侧重于不断变化的治疗场景,特别是新药和生物制剂.
研究的目的:
- 描述乳腺细胞瘤的治疗场景.
- 评估生物和新药在治疗乳腺细胞瘤亚型中的疗效.
- 确定SM,CM和MCS的新兴治疗选择.
主要方法:
- 在PubMed和Scopus数据库中进行了全面的文献搜索.
- 搜索术语包括疾病状态 (CM,SM,MCS) 与生物类或名称相结合.
- 55篇文章符合纳入标准,重点是用氨酸激酶抑制剂 (TKI) 或单克隆抗体治疗.
主要成果:
- 氨酸激酶抑制剂 (TKIs),包括JAK/STAT抑制剂 (JAK1/2i),显示出高疗效.
- 鲁克索利提尼布 (一个JAK1/2i) 在所有接受治疗的患者中显示完全消失 (n=4).
- 单克隆抗体在90.6%的患者 (n=125) 中有效,TCI在90% (n=698) 中有效.
结论:
- JAK1/2抑制剂,TKI和单克隆抗体在治疗巨细胞瘤时有效.
- 这些新型药物显示出成功治疗和改善MS,CM和MCS的症状的希望.
- 需要进行进一步的临床试验,以充分描述JAK1/2抑制剂疗程.
更多相关视频
11:31Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
Published on: July 4, 2018
12.5K
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.5K
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
238
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
238
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
275
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
275
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
Inflammatory Bowel Disease IV: Pharmacological Management
200
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
200
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
471
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
471
